Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects
INTERVENTIONAL
Inicio: 1 de sept de 2005
ID: NCT00125346
Completado
Fase 3
ClinicalTrials.gov
A 64-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Active Controlled Study to Evaluate the Effect of QVA149 (110/50 μg o.d.) vs NVA237 (50 μg o.d.) and Open-label Tiotropium (18 μg o.d.) on COPD Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 1 de abr de 2010
ID: NCT01120691
Completado
Fase 3
ClinicalTrials.gov
A 24 Week, Placebo-Controlled, Randomized, Parallel Group Study Comparing Roflumilast 500 mcg Daily vs Placebo on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 1 de jun de 2003
ID: NCT00062582
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre 24-week Study to Evaluate the Efficacy and Safety of Mepolizumab Adjunctive Therapy in Subjects With Severe Eosinophilic Asthma on Markers of Asthma Control
INTERVENTIONAL
Inicio: 11 de dic de 2014
ID: NCT02281318
Desconocido
ClinicalTrials.gov
Latin American Pulmonary Hypertension Registry
OBSERVATIONAL
Inicio: 1 de abr de 2014
ID: NCT02570737
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg Compared With Tiotropium 18 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 1 de sept de 2014
ID: NCT02207829
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination With Ipilimumab, or Placebo as Maintenance Therapy in Subjects With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based First Line Chemotherapy (CheckMate 451: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 451)
INTERVENTIONAL
Inicio: 13 de oct de 2015
ID: NCT02538666
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Parallel-group, Open-label Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 26 de sept de 2014
ID: NCT02236611
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
INTERVENTIONAL
Inicio: 20 de oct de 2017
ID: NCT03248128
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With Idiopathic Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 5 de nov de 2018
ID: NCT03733444
Terminado
Fase 3
ClinicalTrials.gov
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 1 de feb de 2006
ID: NCT00300885
Desconocido
Fase 3
ClinicalTrials.gov
A Randomized, Controlled Phase III Trial of Picoplatin and BSC Versus BSC Alone in Patients With Small Cell Lung Cancer (SCLC), Refractory or Progressive Within Six Months of Completing First-Line, Platinum-Containing Chemotherapy.
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00465491
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
INTERVENTIONAL
Inicio: 13 de feb de 2017
ID: NCT03053050
Completado
ClinicalTrials.gov
Analysis of CO2/Volume and CO2-pressure Curves to Detect the Lung's Closing Pressure in Ventilated Patients
OBSERVATIONAL
Inicio: 28 de feb de 2023
ID: NCT05873998
Completado
Fase 2
ClinicalTrials.gov
A Phase II Open Label, Roll Over Study of the Long Term Tolerability, Safety and Efficacy of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 25 de jun de 2010
ID: NCT01170065
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Salmeterol Xinafoate/ Fluticasone Propionate Combination
INTERVENTIONAL
Inicio: 1 de may de 2011
ID: NCT01321463
Completado
Fase 3
ClinicalTrials.gov
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis- A Safety and Efficacy Study
INTERVENTIONAL
Inicio: 1 de sept de 2008
ID: NCT00630812
Completado
Fase 3
ClinicalTrials.gov
International Randomized Double Blind Study Evaluating the Efficacy and the Safety of Clopidogrel 0.2 mg/kg Once Daily Versus Placebo in Neonates and Infants With Cyanotic Congenital Heart Disease Palliated With Systemic to Pulmonary Artery Shunt
INTERVENTIONAL
Inicio: 1 de nov de 2006
ID: NCT00396877
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
INTERVENTIONAL
Inicio: 2 de may de 2013
ID: NCT01764841
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Clarithromycin Extended Release for the Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults
INTERVENTIONAL
Inicio: 1 de ene de 2003
ID: NCT00643227
Anterior
1
...
34
35
36
...
434
Siguiente
Filtros